Topics:

Lung Cancer

ASCO Endorses Lung Cancer Guidelines for Molecular Testing

ASCO has endorsed a clinical practice guideline from several associations on when to offer molecular testing for EGFR and ALK mutations in lung cancer patients.

Lung Cancer

A classification system known as Lung-RADS reduced false positive rates but also decreased the sensitivity of low-dose CT screening compared with NLST standards.

In a phase II study, the use of maintenance sunitinib improved progression-free survival among patients with untreated extensive-stage small-cell lung cancer.

Changing smoking habits may require more sensitive lung cancer screening criteria to include as many high-risk individuals as possible.

Patients with lung and colorectal cancer who understood that chemotherapy would not cure them were no less likely to receive chemotherapy at the end of life.

CMS released their final decision for lung cancer screening with low-dose CT.

A new study clarifies the link between metformin and lung cancer. Perhaps not surprisingly, a smoking habit (or lack of it) substantially affects risk.

In patients with diabetes, the use of metformin did not reduce the risk of lung cancer overall, but the risk was reduced among patients who never smoked.

Pages

Subscribe to Lung Cancer on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.